Boom fabulous news
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.93%
!
$13.70

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.70 |
Change
0.390(2.93%) |
Mkt cap ! $1.668B |
Open | High | Low | Value | Volume |
$13.50 | $13.74 | $12.96 | $1.909M | 142.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 582 | $13.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.71 | 3672 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 270 | 13.550 |
1 | 225 | 13.540 |
4 | 656 | 13.530 |
3 | 478 | 13.520 |
4 | 497 | 13.510 |
Price($) | Vol. | No. |
---|---|---|
13.570 | 738 | 4 |
13.580 | 1100 | 2 |
13.590 | 960 | 5 |
13.600 | 500 | 4 |
13.610 | 1747 | 6 |
Last trade - 10.59am 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online